Stem cells as the root of pancreatic ductal adenocarcinoma

被引:37
作者
Balic, Anamaria [1 ]
Dorado, Jorge [1 ]
Alonso-Gomez, Mercedes [1 ]
Heeschen, Christopher [1 ]
机构
[1] Spanish Natl Canc Res Ctr CNIO, Stem Cell & Canc Grp, Clin Res Programme, Madrid 28029, Spain
关键词
Pancreatic cancer; Cancer stem cells; Tumor-initiating cells; Inflammation; Targeted therapy; CIRCULATING TUMOR-CELLS; HEDGEHOG PATHWAY; CANCER-CELLS; SIGNALING PATHWAYS; DOWN-REGULATION; MOUSE MODEL; C-MET; CXCR4; GEMCITABINE; EXPRESSION;
D O I
10.1016/j.yexcr.2011.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Emerging evidence suggests that stem cells play a crucial role not only in the generation and maintenance of different tissues, but also in the development and progression of malignancies. For the many solid cancers, it has now been shown that they harbor a distinct subpopulation of cancer cells that bear stem cell features and therefore, these cells are termed cancer stem cells (CSC) or tumor-propagating cells. CSC are exclusively tumorigenic and essential drivers for tumor progression and metastasis. Moreover, it has been shown that pancreatic ductal adenocarcinoma does not only contain one homogeneous population of CSC rather than diverse subpopulations that may have evolved during tumor progression. One of these populations is called migrating CSC and can be characterized by CXCR4 co-expression. Only these cells are capable of evading the primary tumor and traveling to distant sites such as the liver as the preferred site of metastatic spread. Clinically even more important, however, is the observation that CSC are highly resistant to chemo- and radiotherapy resulting in their relative enrichment during treatment and rapid relapse of disease. Many laboratories are now working on the further in-depth characterization of these cells, which may eventually allow for the identification of their Achilles heal and lead to novel treatment modalities for fighting this deadly disease. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:691 / 704
页数:14
相关论文
共 50 条
  • [21] Biological and clinical relevance of stem cells in pancreatic adenocarcinoma
    Rasheed, Zeshaan A.
    Matsui, William
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 15 - 18
  • [22] Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
    Amantini, Consuelo
    Morelli, Maria Beatrice
    Nabissi, Massimo
    Piva, Francesco
    Marinelli, Oliviero
    Maggio, Federica
    Bianchi, Francesca
    Bittoni, Alessandro
    Berardi, Rossana
    Giampieri, Riccardo
    Santoni, Giorgio
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [23] Clinical Potential of MicroRNAs in Pancreatic Ductal Adenocarcinoma
    Steele, Colin W.
    Oien, Karin A.
    McKay, Colin J.
    Jamieson, Nigel B.
    PANCREAS, 2011, 40 (08) : 1165 - 1171
  • [24] Repurposed Drugs in Pancreatic Ductal Adenocarcinoma An Update
    Ilmer, Matthias
    Westphalen, C. Benedikt
    Niess, Hanno
    D'Haese, Jan G.
    Angele, Martin K.
    Werner, Jens
    Renz, Bernhard W.
    CANCER JOURNAL, 2019, 25 (02) : 134 - 138
  • [25] Targeting hedgehog signaling in pancreatic ductal adenocarcinoma
    Quatannens, Delphine
    Verhoeven, Yannick
    Van Dam, Peter
    Lardon, Filip
    Prenen, Hans
    Roeyen, Geert
    Peeters, Marc
    Smits, Evelien L. J.
    Van Audenaerde, Jonas
    PHARMACOLOGY & THERAPEUTICS, 2022, 236
  • [26] Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
    Sahin, I. H.
    Askan, G.
    Hu, Z. I.
    O'Reilly, E. M.
    ANNALS OF ONCOLOGY, 2017, 28 (12) : 2950 - 2961
  • [27] Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
    Chandana, Sreenivasa
    Babiker, Hani M.
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (02) : 161 - 177
  • [28] MicroRNAs in pancreatic ductal adenocarcinoma
    Park, Jong Y.
    Helm, James
    Coppola, Domenico
    Kim, Donghwa
    Malafa, Mokenge
    Kim, Seung Joon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (07) : 817 - 827
  • [29] Hypoxia and pancreatic ductal adenocarcinoma
    Yamasaki, Akio
    Yanai, Kosuke
    Onishi, Hideya
    CANCER LETTERS, 2020, 484 : 9 - 15
  • [30] Biomarkers in pancreatic ductal adenocarcinoma
    Gallego, J.
    Lopez, C.
    Pazo-Cid, R.
    Lopez-Rios, F.
    Carrato, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (12) : 1430 - 1437